- Home
- GRWG vs KPTI Comparison
GRWG vs KPTI Comparison
Compare GRWG & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- KPTI
- Stock Information
- Founded
- GRWG 2008
- KPTI 2008
- Country
- GRWG United States
- KPTI United States
- Employees
- GRWG N/A
- KPTI N/A
- Industry
- GRWG RETAIL: Building Materials
- KPTI Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- KPTI Health Care
- Exchange
- GRWG Nasdaq
- KPTI Nasdaq
- Market Cap
- GRWG 88.9M
- KPTI 90.7M
- IPO Year
- GRWG N/A
- KPTI 2013
- Fundamental
- Price
- GRWG $1.49
- KPTI $0.69
- Analyst Decision
- GRWG Hold
- KPTI Strong Buy
- Analyst Count
- GRWG 5
- KPTI 4
- Target Price
- GRWG $2.75
- KPTI $5.00
- AVG Volume (30 Days)
- GRWG 708.5K
- KPTI 1.0M
- Earning Date
- GRWG 03-12-2025
- KPTI 02-27-2025
- Dividend Yield
- GRWG N/A
- KPTI N/A
- EPS Growth
- GRWG N/A
- KPTI N/A
- EPS
- GRWG N/A
- KPTI N/A
- Revenue
- GRWG $200,882,000.00
- KPTI $148,442,000.00
- Revenue This Year
- GRWG N/A
- KPTI $5.47
- Revenue Next Year
- GRWG N/A
- KPTI $6.33
- P/E Ratio
- GRWG N/A
- KPTI N/A
- Revenue Growth
- GRWG N/A
- KPTI 1.77
- 52 Week Low
- GRWG $1.49
- KPTI $0.58
- 52 Week High
- GRWG $3.38
- KPTI $1.95
- Technical
- Relative Strength Index (RSI)
- GRWG 34.09
- KPTI 47.36
- Support Level
- GRWG $1.51
- KPTI $0.61
- Resistance Level
- GRWG $1.58
- KPTI $0.73
- Average True Range (ATR)
- GRWG 0.10
- KPTI 0.07
- MACD
- GRWG -0.01
- KPTI -0.00
- Stochastic Oscillator
- GRWG 2.56
- KPTI 34.06
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.